A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Hemophilia B

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality, China
Contact: Study coordinator (Lei Zhang, MD) · zhanglei1@ihcams.ac.cn

Study leads

Lei Zhang, MD
Principal Investigator
Institute of Hematology & Blood Diseases Hospital, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Efficacy and Safety of ZS801 in Chinese Hemophilia B Patients.

Hemophilia B

Abroad (travel likely)Recruiting

Tianjin, China

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Hemophilia B

Abroad (travel likely)RecruitingPHASE1, PHASE2

Los Angeles, United States · Los Angeles, United States

An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency

Hemophilia A · Hemophilia B · Factor VII Deficiency

Abroad (travel likely)RecruitingPHASE1, PHASE2

Changsha, China · Hefei, China

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

Hemophilia B

Abroad (travel likely)RecruitingPHASE1, PHASE2

Homyel, Belarus · Minsk, Belarus